• Ophthalmology · Sep 2002

    Loss of stereopsis with optic chiasmal lesions and stereoscopic tests as a differential test.

    • Toshie Hirai, Yasuki Ito, Masashi Arai, Yoshie Ota, Takeshi Kojima, Miho Sato, and Yozo Miyake.
    • Department of Ophthalmology, Nagoya University, School of Medicine, Nagoya, Japan. toshieh@med.nagoya-u.ac.jp
    • Ophthalmology. 2002 Sep 1;109(9):1692-702.

    ObjectiveTo identify and characterize the loss of stereopsis observed in patients with lesions of the optic chiasm.Study DesignCross-sectional study.ParticipantsForty-three patients who had good visual acuity with orthophoria and without strabismologic histories were divided into two groups. Group 1 consisted of 13 patients with lesions involving the optic chiasm (regardless of their visual field loss) diagnosed by magnetic resonance imaging findings. Group 2 (control group) consisted of 30 patients who had large absolute visual field defects as a result of other causes, including 11 intracranial disorders other than optic chiasmal lesions, 11 cases of open-angle glaucoma, and 8 patients with lesions of the retina.MethodsThe stereoacuity and visual field in each case in group 1 (before and after surgery) and group 2 were assessed, and the results were compared.Main Outcome MeasuresStereoacuity was assessed by the Titmus stereo test (normal value for circle, 6/9; 80 seconds of arc) and by Lang-stereotest (normal value for circle, 3/3; 350 seconds of arc). Visual field was evaluated by Goldmann and Humphrey perimetry (conventional perimetry), the starlight test (binocular visual field test), and scanning laser ophthalmoscopic microperimetry (microperimetry).ResultsBefore surgery, 11 of 13 cases (85%) in group 1 failed stereo tests, and after surgery, 5 of 13 cases (38%) in group 1 failed stereo tests. Before surgery, four patients who failed stereo tests showed no absolute scotoma by Humphrey or Goldmann analysis; after surgery, one patient who failed stereo tests showed no absolute scotoma by Humphrey or Goldmann analysis. However, starlight testing showed complete bitemporal hemianopsia only under binocular conditions, and microperimetry demonstrated a relative bitemporal hemianopsia at the fixating point. No patient failed in the Titmus circle test, but one patient in group 2 failed the Lang test (3%). The patients with chiasmal lesions significantly lost the ability of stereopsis compared with other diseases (group 1 [before or after surgery] vs. group 2, P < 0.001, Fisher's exact test). Conventional perimetry was unable to measure scotomas within 3 degrees of the fixation point, which is the key area for acute foveal stereopsis, because of an attached observational mirror.ConclusionsThe difficulty with stereopsis in patients with lesions of the optic chiasm is most likely caused by the compression of the decussating optic nerve fibers resulting in the loss of an overlapping visual field at the fixation point. Stereo tests were demonstrated to be simple and effective adjunctive tests for suspected chiasmal compression.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.